Artemisinin resistant falciparum malaria in Myanmar
<p>Artemisinin-based combination therapy (ACT) is first-line treatment for <em>Plasmodium falciparum</em> malaria globally but artemisinin resistance is now prevalent across Southeast Asia. Myanmar has the highest malaria burden in the region, and determining the prevalence of arte...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Published: |
2015
|